Upgrade to SI Premium - Free Trial

Moderna (MRNA) PT Raised to $38 at RBC Capital

May 1, 2026 12:25 PM
RBC Capital analyst Luca Issi raised the price target on Moderna (NASDAQ: MRNA) to $38.00 (from $35.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change